New patent for Sanofi Us drug TOUJEO SOLOSTAR

Annual Drug Patent Expirations for TOUJEO+SOLOSTAR
Annual Drug Patent Expirations for TOUJEO+SOLOSTAR

Toujeo Solostar is a drug marketed by Sanofi Us Services
and is included in one NDA. It is available from two suppliers. There are ten patents protecting this drug.

This drug has one hundred and seventy-one patent family members in forty-one countries.

The generic ingredient in TOUJEO SOLOSTAR is insulin glargine recombinant. Two suppliers are listed for this compound. Additional details are available on the insulin glargine recombinant profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,
contact admin@DrugPatentWatch.com
or visit www.DrugPatentWatch.com